Skip to main content
. 2023 May 8;14:1175198. doi: 10.3389/fendo.2023.1175198

Figure 3.

Figure 3

FPG change from baseline with GKA treatment versus placebo in type 2 diabetes. FPG, fasting plasma glucose; GKA, glucokinase activator; ES, effect size; CI, confidential interval.